Greater Manchester Medicines Management Group

Greater Manchester Clinical Standards Board

NHS

News Summary

From this page you will be able to access a summary of additions or changes to the GMMMG website on a monthly basis

February 2019

 

Formulary and Managed Entry Subgroup (FMESG)

11.2.19

Following GM-wide consultation and support from CSB, actions from the October meeting of FMESG have been published. Changes include:

  • Formulary was updated to reflect NICE technology appraisal of tofacitinib for psoriatic arthritis
  • MHRA Drug Safety updates were added to formulary
  • Semaglutide was added to formulary as the first choice weekly GLP-1 analogue
  • Dapoxetine for treatment of premature ejaculation was added to the DNP list

The formulary and RAG list have been updated to reflect these changes.

11.2.19

Following their regular quarterly review, the reviewed and updated GM Antimicrobial Guidelines are now available on the GMMMG website

6.2.19

The following actions were proposed at the January 2019  FMESG meeting and will be sent to CSB for pre-approval. We now seek comments on these proposals.  This consultation period is open until 5pm on Tuesday 19th March.

Pathways and Guidelines Development Subgroup (PaGDSG)

6.2.19

On behalf of the GMMMG Pathways and Guidelines Development Subgroup, a Greater Manchester-wide Guidance for Overactive Bladder in Adults is in development. We now seek comments on this draft.  This consultation period is open until 5pm on Tuesday 19th March.

6.2.19

On behalf of the GMMMG Pathways and Guidelines Development Subgroup,  Greater Manchester-wide Guidance for Tobacco Addiction in Adults plus additional prescribing notes  are in development. We now seek comments on these drafts.  This consultation period is open until 5pm on Tuesday 19th March

6.2.19

On behalf of the GMMMG Pathways and Guidelines Development Subgroup, an update to the Greater Manchester-wide Shared Care Protocol  for Atomoxetine, Guanfacine, Lisdexamfetamine and Methylphenidate for ADHD in Adults is in development. We now seek comments on this draft.  This consultation period is open until 5pm on Tuesday 19th March.

6.2.19

On behalf of the GMMMG Pathways and Guidelines Development Subgroup, a Greater Manchester-wide Shared Care Protocol for Azathioprine for Autoimmune Hepatitis in Adults is in development. We now seek comments on this draft.  This consultation period is open until 19/03/19.

<< Back

Line

TERMS AND CONDITIONS    |    CONTACT US    |    ABOUT US    |    ARCHIVE

RSS Feed
 
spacer